For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.
Keep Reading →
August 20 - News
A rising tide lifts all boats, but the opposite isn't true in the stock market. The major indexes slipped this week, while a handful of health-care stocks soared.
Keep Reading →
August 17 - News
Jeffrey Ubben is the founder of one of the hedge funds we track, ValueAct Capital Management.
Keep Reading →
August 15 - Hedge Funds
Studies show that stocks bought by insiders narrowly outperform the market (read our analysis of studies on insider trading).
Keep Reading →
August 14 - Insider Trading
Large healthcare companies are facing revenue declines due to expiring patents.
Keep Reading →
July 25 - News
According to IMS health report, the global pharmaceutical industry is expected to grow at a CAGR of 4.5% in the next five years to reach $1.20 trillion in 2017, from $963 billion...
Keep Reading →
July 2 - News
Courtesy of Insider Insights, I have compiled a list of significant insider/institutional purchases and sales that have been filed with the SEC over the last week--but does this...
Keep Reading →
July 2 - Insider Trading
Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August 2012.
Keep Reading →
June 27 - News
The healthcare sector has always been a subject of great interest to investors and analysts alike.
Keep Reading →
June 21 - News
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
Keep Reading →
June 19 - News
According to a filing with the SEC, between June 11th and 12th Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Board member Lloyd Segal directly purchased 2,800 shares of the stock...
Keep Reading →
June 14 - Insider Trading
Searching for potential stock investments can be a daunting task.
Keep Reading →
June 13 - Hedge Funds
While the debate goes on whether increasing output by acquiring new businesses through mergers, acquisitions and takeovers is the right way forward, the biopharmaceutical industry...
Keep Reading →
June 13 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been on an acquisition spree. Its latest purchase is Bausch + Lomb in an all-cash deal worth $8.7 billion.
Keep Reading →
June 12 - News
Everyone loves a defensive growth story, and there aren’t many better companies in the category than The Cooper Companies, Inc. (NYSE:COO).
Keep Reading →
June 12 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stirred the merger and acquisition space once again with its announcement that it is about to acquire multinational eye health firm...
Keep Reading →
June 10 - News
In one of the more surprising deals in some time, pork producer Smithfield Foods, Inc.
Keep Reading →
June 6 - News
If there were ever any advice I'd wish to impart to the management at Endo Health Solutions Inc (NASDAQ:ENDP)'s subsidiary Endo Pharmaceuticals, it would be that sometimes it'...
Keep Reading →
June 3 - News
The pharmaceutical industry is getting hotter with increasing M&A activities.
Keep Reading →
May 30 - News
For big companies like Apple Inc. (NASDAQ:AAPL) and Google Inc (NASDAQ:GOOG), it is unreasonable to expect that your shares will double in value.
Keep Reading →
May 30 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) jumped 8% on Monday, giving the stock a two-day 22% surge.
Keep Reading →
May 28 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has built a unique, winning drug business by acquiring underperforming niche product franchises and incorporating them into its efficient...
Keep Reading →
May 28 - News
Following the three-day holiday weekend, investors came back to work to find the stock market soaring, with the Dow Jones Industrials climbing more than 200 points by 10:45 a...
Keep Reading →
May 28 - News
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in 37 hedge funds' portfolio at the end of March.
Keep Reading →
May 24 - News
News that Montreal-based Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was in talks to merge with Parsippany, New Jersey-based Actavis Inc (NYSE:ACT) emerged barely a week after...
Keep Reading →
May 15 - News
Editor's Note: Related Tickers: Amarin Corporation plc (ADR) (NASDAQ:AMRN), GlaxoSmithKline plc (ADR) (NYSE:GSK), Abbott Laboratories (NYSE:ABT), Valeant Pharmaceuticals Intl ...
Keep Reading →
April 23 - News
Roche Holding Ltd. (ADR) (PINK:RHHBY) and ISIS Pharmaceuticals, Inc.
Keep Reading →
April 8 - News
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Keep Reading →
April 7 - News
The drug development field is a potentially lucrative, although always dangerous area for small companies and their investors to participate in.
Keep Reading →
March 27 - News
The Sequoia Fund is a mutual fund founded by William Ruane in 1970. Both Ruane and Warren Buffett took a class from Benjamin Graham, the father of value investing, in 1951.
Keep Reading →
March 22 - News
To most stock holders, hedge funds are viewed as slow, old financial vehicles of years past.
Keep Reading →
March 21 - News
After reviewing the hedge fund filings for last quarter, there are five stocks that stood out as being loved by hedge funds. The hedge fund activity in these five stocks were...
Keep Reading →
March 15 - News
We have spent the last couple weeks studying 13F filings from hedge funds and other notable investors. 13Fs disclose many long equity positions in U.S.
Keep Reading →
February 27 - Hedge Funds
Endo Health Solutions Inc (NASDAQ:ENDP), a diversified healthcare company specializing in pain medication, has been sending out mixed signals recently.
Keep Reading →
February 26 - News
Endo Health Solutions Inc (NASDAQ:ENDP) shares popped more than 17% last week on rumors of exploratory talks with potential buyers including Valeant Pharmaceuticals Intl Inc (...
Keep Reading →
February 8 - News
I must confess I am finding the current market to be one of the most frustrating periods of my investing life.
Keep Reading →
February 8 - News
